Market Research Logo

US Market Report for Uterine Fibroid Embolization Devices - MedCore

Uterine fibroid embolization (UFE), also known as uterine artery embolization (UAE) is a radiology treatment for fibroids. Fibroids, also known as myomas, are masses of muscle tissue and fiber located on the wall of the uterus that can cause heavy bleeding and pain. Fibroids depend on the uterine arteries for nourishment, and they take significant blood supply from these vessels. UFE restricts blood flow to fibroids, causing them to shrink significantly. This procedure does not involve general anesthesia and is appropriate for women who want an alternative to a myomectomy, also known as fibroidectomy. It is a much less invasive way to treat fibroids than a hysterectomy, has a much shorter recovery time and leaves almost no scarring. The effects of UFE on fertility are being researched; some results suggest that fertility after UFE is comparable to fertility after myomectomy.

During this procedure, a small incision is made in the groin, and a small catheter is inserted into the nearby artery. X-ray guidance is used to move the catheter through the artery into the uterus. A mixture of minuscule plastic particles and X-ray dye is then injected into the artery, flowing and accumulating in the fibroids and blocking the blood supply. The flow of particles is carefully monitored with the X-ray equipment by watching the flow of dye. This procedure can take anywhere from 40 minutes to three hours to complete. The fibroids shrink and disappear over a period of several months.


FULL SUITE EXECUTIVE SUMMARY
1.1 U.S. GYNECOLOGICAL DEVICE MARKET
1.2 TREND ANALYSIS
1.3 PROCEDURE NUMBERS
1.4 ASSISTED REPRODUCTION TECHNOLOGY DEVICE MARKET
1.5 GLOBAL ENDOMETRIAL ABLATION MARKET
1.6 RESECTOSCOPIC ENDOMETRIAL ABLATION & RESECTION DEVICE MARKET
1.7 UTERINE FIBROID EMBOLIZATION DEVICE MARKET
1.8 HYSTEROSCOPE MARKET
1.9 COLPOSCOPE MARKET
1.10 FEMALE STERILIZATION DEVICE MARKET
1.11 FEMALE URINARY INCONTINENCE SLING MARKET
1.12 PELVIC FLOOR ELECTRICAL STIMULATION DEVICE MARKET
1.13 FLUID MANAGEMENT DEVICE MARKET
1.14 PELVIC ORGAN PROLAPSE REPAIR DEVICE MARKET
1.15 HYSTEROSALPINGOGRAPHY (HSG) CATHETER MARKET
1.16 COMPETITIVE ANALYSIS
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
UTERINE FIBROID EMBOLIZATION DEVICE MARKET
3.1 INTRODUCTION
3.1.1 Microspheres
3.1.2 Polyvinyl Alcohol Particles
3.1.3 Drug-eluting Particles
3.2 MARKET OVERVIEW
3.3 MARKET ANALYSIS AND FORECAST
3.3.1 Microsphere Market
3.3.2 PVA Particle Market
3.4 DRIVERS AND LIMITERS
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 COMPETITIVE ANALYSIS
ABBREVIATIONS
List of Chart
Chart 1 1: Gynecological Device Market, U.S., 2012 – 2022 1
Chart 1 2: Gynecological Device Market CAGR by Segment, U.S., 2015 – 2022 2
Chart 1 3: Market Share by Segment, Assisted Reproduction Technology Device Market, U.S., 2015 4
Chart 1 4: Uterine Fibroid Embolization Market Breakdown, U.S., 2015 & 2022 6
Chart 1 5: Hysteroscope Market Metrics by Segment, U.S., 2015 7
Chart 1 6: Female Urinary Incontinence Sling Market by Segment, U.S., 2015 9
Chart 1 7: Market Share Index, Pelvic Floor Electrical Stimulation Device Market, U.S., 2015 10
Chart 1 8: Increase in Units Sold, HSG Catheter Market, U.S., 2015 – 2020 12
Chart 1 9: Leading Competitors, Gynecological Device Market, U.S., 2015 13
Chart 3 1: Uterine Fibroid Embolization Device Market by Segment, U.S., 2012 – 2022 30
Chart 3 2: Uterine Fibroid Embolization Device Market Breakdown, U.S., 2015 31
Chart 3 3: Uterine Fibroid Embolization Device Market Breakdown, U.S., 2022 31
Chart 3 4: Microsphere Market, U.S., 2012 – 2022 33
Chart 3 5: PVA Particle Market, U.S., 2012 – 2022 35
Chart 3 6: Leading Competitors, Uterine Fibroid Embolization Device Market, U.S., 2015 40
List of Figures
Figure 1 1: Procedural Codes, U.S., 2015 3
Figure 3 1: Uterine Fibroid Embolization Device Market by Segment, U.S., 2012 – 2022 (US$M) 30
Figure 3 2: Microsphere Market, U.S., 2012 – 2022 32
Figure 3 3: PVA Particle Market, U.S., 2012 – 2022 34
Figure 3 4: Drivers and Limiters, Uterine Fibroid Embolization Device Market, U.S., 2015 37
Figure 3 5: Leading Competitors, Uterine Fibroid Embolization Device Market, U.S., 2015 39

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report